From: Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
Gene | Alternative names | Altered expressiona (mRNA) | OSb (mRNA) | Comments |
---|---|---|---|---|
CD244 | 2B4 | No | No | Â |
TNFRSF9 | 4-1BB | No | No | Â |
ANGPTL7 | CDT6 | No | No | Â |
CD80 | B7-1 | No | No | Â |
CD86 | B7-2 | No | No | Â |
ICOSLG | B7-H2 | No | No | Â |
CD276 | B7-H3 | N/A | Yes (p = 0.039) | High expression associated with poor OS |
VTCN1 | B7-H4 | No | No | Â |
HHLA2 | B7-H5 | No | No | Â |
NCR3LG1 | B7-H6 | N/A | Â | Not found in UALCAN |
BTLA | Â | N/A | No | Â |
BTN1A1 | BTN | No | No | Â |
BTN3A1 | CD277 | Yes (p = 0.029) | Yes (p = 0.0093) | Upregulated in MPM High expression associated with better OS |
BTN3A3 | BTF3 | Yes (p = 0.042) | Yes (p = 0.0065) | Upregulated in MPM High expression associated with better OS |
PVR | CD155 | No | Yes (p = 0.023) | High expression associated with poor OS |
CD160 | BY55 | No | No | Â |
LY9 | CD229 | No | No | Â |
CD28 | Tp44 | No | No | Â |
TNFRSF8 | CD30 | No | No | Â |
CD40 | TNFRSF5 | No | No | Â |
CD47 | MER6, IAP | Yes (p = 0.012) | No | Upregulated in MPM |
CD48 | BLAST1 | No | No | Â |
CD84 | SLAMF5 | No | Yes (p = 0.042) | High expression associated with poor OS |
CD96 | TACTILE | No | No | Â |
CTLA-4 | CD152 | No | No | Â |
CD226 | DNAM-1 | No | No | Â |
LGALS9 | Galectin-9 | No | No | Â |
TNFRSF18 | GITR | N/A | No | Â |
TNFRSF14 | HVEM | No | Yes (p = 0.019) | High expression associated with better OS |
TIM3 | HAVCR2 | No | No | Â |
ICOS | AILIM | No | No | Â |
LAG3 | CD223 | Yes (p = 0.011) | Yes (p = 0.021) | Upregulated in MPM High expression associated with better OS |
LAIR-1 | Â | No | No | Â |
LAIR-2 | CD306 | No | No | Â |
LILRA2 | LIR7, CD85H | No | Yes (p = 0.038) | High expression associated with better OS |
LILRA3 | LIR4, CD85E | No | No | Â |
LILRA5 | LIR9, CD85F | No | No | Â |
LILRB1 | LIR1, CD85 | No | No | Â |
LILRB2 | LIR2, CD85D | No | No | Â |
LILRB3 | LIR3, CD85A | No | No | Â |
LILRB4 | LIR5, CD85K | No | No | Â |
LILRB5 | LIR8, CD85C | No | No | Â |
Nectin-1 | PVRL1 | No | Yes (p = 0.0042) | High expression associated with poor OS |
Nectin-2 | PVRL2 | No | No | Â |
Nectin-3 | PVRL3 | Yes (p = 0.012) | Yes (p = 0.024) | Upregulated in MPM High expression associated with poor OS |
NCR3 | NKp30 | No | No | Â |
SLAMF6 | NTB-A | N/A | No | Â |
OX40 | TNFRSF4 | No | No | Â |
OX40L | TNFSF4 | Yes (p = 0.047) | Yes (p = 0.00018) | High expression associated with poor OS |
PD1 | CD279 | No | No | Â |
PD-L1 | CD274 | N/A | No | Â |
PD-L2 | B7DC | No | No | Â |
PVRIG | CD112R | No | No | Â |
SIRPA | PTPNS1 | No | Yes (p = 0.0091) | High expression associated with better OS |
SIRPG | SIRP gamma | No | No | Â |
SIRPB1 | SIRP-beta 1 | Yes (p = 7.92 × 10–7) | No | Upregulated in MPM |
SIRPB2 | Â | N/A | No | Â |
SLAMF1 | CD150 | No | No | Â |
SLAMF7 | CD319 | No | No | Â |
TIGIT | Â | N/A | No | Â |
VISTA | VSIR, C10ORF54 | N/A | Yes (p = 0.00093) | High expression associated with better OS |
VSIG3 | IGSF11 | N/A | No | Ligand of VISTA |
VSIG4 | CRIG | No | No | Â |